Read by QxMD icon Read

Sexual dysfonction

Jiwon Oh, Marie-Sarah Gagné-Brosseau, Melanie Guenette, Catherine Larochelle, François Lemieux, Suresh Menon, Sarah A Morrow, Laurence Poliquin-Lasnier, Chantal Roy-Hewitson, Carolina Rush, Anne-Marie Trudelle, Paul S Giacomini
The objective of this study was to develop a shared-care model to enable primary-care physicians to participate more fully in meeting the complex, multidisciplinary healthcare needs of patients with multiple sclerosis (MS). DESIGN: The design consisted of development of consensus recommendations and a shared-care algorithm. PARTICIPANTS: A working group of 11 Canadian neurologists involved in the management of patients with MS were included in this study. MAIN MESSAGE: The clinical management of patients with multiple sclerosis is increasing in complexity as new disease-modifying therapies (DMTs) become available, and ongoing safety monitoring is required...
May 2018: Canadian Journal of Neurological Sciences. le Journal Canadien des Sciences Neurologiques
Benjamin Alexandre, Antoine Lemaire, Pierre Desvaux, Edouard Amar
INTRODUCTION: Since the availability of oral type 5 phosphodiesterase (PDE5) inhibitors for the treatment of erectile dysfunction (ED), patients' views on the use of intracavernous injections (ICI) of prostaglandin E1 (PGE1) may have changed. AIM: To assess the satisfaction of patients with long-term ICI. METHODS: Patients with ED (>18 years old) who had used ICI of PGE1 for at least 3 months were asked to complete the "EASY" (Evaluation de l'Acceptation des injectionS dans la dYsfonction érectile) questionnaire...
March 2007: Journal of Sexual Medicine
P Desvaux, B Alexandre
The primary objective of the EASY survey (Evaluation de l'Acceptation deS injections dans la dYsfonction érectile) was to study the feelings of patients treated for erectile disorders with long-term intracavernous injections of prostaglandin E1. The major criteria for abandoning treatment with IPDE 5 are, in descending order, inefficacy, cost and poor tolerance. Regarding the results with intracavernous injections of Edex, around 80% of patients were satisfied; 70 to 80% of those treated for risk factors and/or cardiovascular or neurological diseases and 55% of those treated following cancer of the prostate claimed that their sex life had improved...
July 23, 2005: La Presse Médicale
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"